ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Preformed Anti-MICA Antibodies Negatively Impact Renal Allograft Evolution in Early Post-Transplantation Period

    E. Sánchez-Zapardiel, M. Castro-Panete, M. Castillo-Rama, P. Morales, D. Lora-Pablos, D. Valero-Hervás, R. Ruiz-García, J. Apaza, P. Talayero, A. Amado, J. Morales, E. Paz-Artal

    Immunology, Madrid, Spain; Epidemiology, Madrid, Spain; Nephrology, H. 12 Octubre, Madrid, Spain; I+12 Research Institute, Madrid, Spain

    We analyzed the role of preformed a-MICA antibodies (Abs) in kidney recipients (n=727), transplanted between 2005 and 2011. Fifty two patients (pts) had preformed a-MICA…
  • 2013 American Transplant Congress

    Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial

    P. De Simone, O. Detry, G. Kintmalm, J. Goss, P. McCormick, M. Rossi, A. Moya, P. Lopez, G. Junge, G. Dong, D. Joseph, C. Duvoux

    For the H2304 Study Group, Pisa, Italy; Novartis Pharma AG, Basel, Switzerland; Novartis Pharmaceuticals Corporation, New Jersey

    mTOR inhibitors have the potential to reduce calcineurin inhibitor nephrotoxicity by minimizing or eliminating the need for their use. The 12 month (M) results of…
  • 2013 American Transplant Congress

    Impact of mTOR and Calcineurin Inhibition on Lipid and Glucose Metabolism – 24 Month Assessment in De Novo Liver Transplant Recipients Treated with Everolimus and Tacrolimus

    L. Fischer, P. De Simone, F. Saliba, J. Fung, G. Dong, P. Lopez, S. Kohler, G. Junge

    For the H2304 Investigators, Hamburg, Germany; Novartis Pharma AG, Basel, Switzerland

    Immunosuppressants, particularly corticosteroids (CS) and calcineurin inhibitors used after liver transplantation (LTx) can adversely affect lipid metabolism. mTOR inhibition blocks insulin-stimulated lipoprotein lipase and can…
  • 2013 American Transplant Congress

    There Is No Difference in Patient Survival after Liver Transplantation between Induction with Rabbit ATG and Basiliximab in Recipients with HCV, However, There Appears To Be Less Severe Fibrosis with rATG

    M. Montenovo, J. Brandenberger, R. Bakthavatsalam, J. Haldorson, A. Dick, J. Perkins, R. Carithers, R. Bhattacharya, L. Yu, I. Liou, C. Landis, M. Yey, J. Reyes, S. Rayhill

    University of Washington, Seattle

    rATG has gained acceptance for induction in liver transplantation. However, due to its strength as an immunosuppressive agent, there is concern that it may be…
  • 2013 American Transplant Congress

    Soluble FGL2 Mediates Acute Rejection in Renal Allograft Recipients by Inducing Tubular Epithelial Cells Apoptosis

    Z. Zhao, C. Yang, L. Wang, L. Li, T. Zhao, D. Wu, R. Rong, M. Xu, T. Zhu

    Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Organ Transplantation, Shanghai, China

    Background: Acute rejection (AR), initiated by infiltrating alloreactive T cells, hampers renal allograft survival. Tubular epithelial cells (TECs) are primary target in AR. TECs apoptosis…
  • 2013 American Transplant Congress

    Effect of Nrf2-keap1 Pathway Activation on Human Pancreatic β Cells, The

    Y. Masuda, S. Li, A. Le, M. Hajighasemi-Ossareh, C. Foster, N. Vaziri, H. Ichii

    Surgery, University of California Irvine, Irvine, CA; Medicine, University of California Irvine, Irvine, CA

    Backgrounds: Islets are known to contain low level of antioxidants which renders them vulnerable to oxidative stress. It is also known that islets are exposed…
  • 2013 American Transplant Congress

    Neutralization of Extracellular HMGB1 Suppresses Xeno-Immune Response and Delays Xenograft Rejection in a Rat-to Mouse Cardiac Xenotransplant Model

    G. Chen, J. Li, Y. Ruan, L. Wang, X. Huang, H. Guo, F. Gong

    Institue of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Background: Extracellular HMGB1 has been found to be a potent stimulator for adaptive immune responses. It has been reported that blockade of extracellular HMGB1 significantly…
  • 2013 American Transplant Congress

    Does Extended Criteria Donor Kidney Biopsy Predict Five-Year Patient and Graft Survival?

    G. Ng, S. Faerstain, A. Mehrnia, M. Kamgar, S. Bunnapradist, H. Gritsch

    UCLA David Geffen School of Medicine, Los Angeles, CA

    Purpose: Donor biopsy is frequently used to assess extended criteria donor (ECD) organ quality, but the effect on patient survival and graft survival is less…
  • 2013 American Transplant Congress

    Obesity Is a Major Barrier to Increasing Living Kidney Donation in the United States

    Z. Stewart

    Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA

    Background: The number of living kidney donors has failed to increase in over a decade. There is limited data on the percentage of living kidney…
  • 2013 American Transplant Congress

    Protective Effect of Carbon Monoxide-Releasing Molecules in Renal Ischemia-Reperfusion Injury Is Associated with Profound Inhibition of HMGB1 Cytoplasmic Translocation, The

    G. Chen, Y. Ruan, L. Wang, Y. Xiang, H. Guo, Y. Zhao

    Institue of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Background: carbon monoxide-releasing molecules (CORMs) can significantly protect against renal ischemia-reperfusion injury (IRI), however, the mechanisms have not been fully elucidated. HMGB1 can be passively…
  • « Previous Page
  • 1
  • …
  • 1565
  • 1566
  • 1567
  • 1568
  • 1569
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences